Skip to main content
Erschienen in: Journal of General Internal Medicine 5/2010

01.05.2010 | Original Article

Oversight of Financial Conflicts of Interest in Commercially Sponsored Research in Academic and Nonacademic Settings

verfasst von: Kevin P. Weinfurt, PhD, Mark A. Hall, JD, N. Chantelle Hardy, Joëlle Y. Friedman, MPA, Kevin A. Schulman, MD, Jeremy Sugarman, MD, MPH, MA

Erschienen in: Journal of General Internal Medicine | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

BACKGROUND

Studies of conflicts of interest in clinical research have focused on academic centers, but most clinical research takes place in nonacademic settings.

OBJECTIVE

To compare oversight and management of investigators’ financial relationships in academic and nonacademic research settings.

DESIGN, SETTING, AND PARTICIPANTS

Survey of officials at 199 sites that contributed participants to commercially sponsored phase 3 clinical trials published in JAMA or the New England Journal of Medicine in 2006 and 2007.

MEASUREMENTS AND MAIN RESULTS

Response rates were 66% for academic medical centers, 37% for nonacademic medical centers (inpatient), and 27% for outpatient nonacademic sites. Almost all academic medical centers (97%) and most nonacademic medical centers (87%) followed written conflict-of-interest policies, whereas 44% of outpatient nonacademic sites had written policies (P < 0.001). Academic and nonacademic medical centers relied mainly on internal institutional review boards (69% and 71%, respectively); outpatient nonacademic sites relied primarily on independent institutional review boards (59%; P < 0.001).

CONCLUSIONS

Nonacademic sites have substantially different approaches to the oversight and management of financial relationships in commercially sponsored clinical research than academic medical centers. These differences warrant more attention to how financial relationships are monitored in community research settings.
Literatur
1.
Zurück zum Zitat Lo B, Field MJ. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press; 2009. Lo B, Field MJ. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press; 2009.
2.
Zurück zum Zitat Association of American Medical Colleges Task Force on Financial Conflicts of Interest in Clinical Research, Protecting Subjects, Preserving Trust, Promoting Progress. Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research. Washington, DC: Association of American Medical Colleges; 2001. Association of American Medical Colleges Task Force on Financial Conflicts of Interest in Clinical Research, Protecting Subjects, Preserving Trust, Promoting Progress. Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research. Washington, DC: Association of American Medical Colleges; 2001.
3.
Zurück zum Zitat Association of American Universities Task Force on Research Accountability, Report on Individual and Institutional Financial Conflict of Interest. Washington, DC: Association of American Universities; 2001. Association of American Universities Task Force on Research Accountability, Report on Individual and Institutional Financial Conflict of Interest. Washington, DC: Association of American Universities; 2001.
4.
Zurück zum Zitat Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research. JAMA. 2003;286(4):454–465.CrossRef Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research. JAMA. 2003;286(4):454–465.CrossRef
5.
Zurück zum Zitat Boyd EA, Lipton S, Bero LA. Implementation of financial disclosure policies to manage conflicts of interest. Health Affairs. 2004;23(2):206–214.CrossRefPubMed Boyd EA, Lipton S, Bero LA. Implementation of financial disclosure policies to manage conflicts of interest. Health Affairs. 2004;23(2):206–214.CrossRefPubMed
6.
Zurück zum Zitat Cho MK, Shohara R, Schissel A, Rennie D. Policies on faculty conflicts of interest at US universities. Journal of the American Medical Association. 2000;284(17):2203–2208.CrossRefPubMed Cho MK, Shohara R, Schissel A, Rennie D. Policies on faculty conflicts of interest at US universities. Journal of the American Medical Association. 2000;284(17):2203–2208.CrossRefPubMed
7.
Zurück zum Zitat Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ. Patients’ views on financial conflicts of interest in cancer research trials. New England Journal of Medicine. 2006;355(22):2330–2337.CrossRefPubMed Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ. Patients’ views on financial conflicts of interest in cancer research trials. New England Journal of Medicine. 2006;355(22):2330–2337.CrossRefPubMed
8.
Zurück zum Zitat Korn D. Conflicts of interest in biomedical research. Journal of the American Medical Association. 2000;284(17):2234–2237.CrossRefPubMed Korn D. Conflicts of interest in biomedical research. Journal of the American Medical Association. 2000;284(17):2234–2237.CrossRefPubMed
9.
Zurück zum Zitat Lo B, Wolf L, Berkeley A. Conflict-of-interest policies for investigators in clinical trials. New England Journal of Medicine. 2000;343(22):1616–1620.CrossRefPubMed Lo B, Wolf L, Berkeley A. Conflict-of-interest policies for investigators in clinical trials. New England Journal of Medicine. 2000;343(22):1616–1620.CrossRefPubMed
10.
Zurück zum Zitat McCrary SV, Anderson CB, Jakovljevic J, Khan T, McCullough LB, Wray NP, et al. A national survey of policies on disclosure of conflicts of interest in biomedical research. New England Journal of Medicine. 2000;343(22):1621–1626.CrossRefPubMed McCrary SV, Anderson CB, Jakovljevic J, Khan T, McCullough LB, Wray NP, et al. A national survey of policies on disclosure of conflicts of interest in biomedical research. New England Journal of Medicine. 2000;343(22):1621–1626.CrossRefPubMed
11.
Zurück zum Zitat U.S. General Accounting Office, Biomedical Research: HHS Direction Needed to Address Financial Conflicts of Interest (Washington: U.S. General Accounting Office, 2001 [GAO-02-89]) U.S. General Accounting Office, Biomedical Research: HHS Direction Needed to Address Financial Conflicts of Interest (Washington: U.S. General Accounting Office, 2001 [GAO-02-89])
12.
Zurück zum Zitat Weinfurt KP, Dinan MA, Allsbrook JS, Friedman JY, Hall MA, Schulman KA, et al. Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Academic Medicine. 2006;81(2):113–118.CrossRefPubMed Weinfurt KP, Dinan MA, Allsbrook JS, Friedman JY, Hall MA, Schulman KA, et al. Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Academic Medicine. 2006;81(2):113–118.CrossRefPubMed
13.
Zurück zum Zitat Weinfurt KP, Friedman JY, Dinan MA, Allsbrook JS, Hall MA, Dhillon JK, et al. Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. Journal of Law, Medicine & Ethics. 2006;34(3):581–591.CrossRef Weinfurt KP, Friedman JY, Dinan MA, Allsbrook JS, Hall MA, Dhillon JK, et al. Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. Journal of Law, Medicine & Ethics. 2006;34(3):581–591.CrossRef
14.
Zurück zum Zitat Dinan MA, Weinfurt KP, Friedman JY, Allsbrook JS, Gottlieb J, Schulman KA, et al. Comparison of conflict of interest policies and reported practices in academic medical centers in the United States. Accountability in Research. 2006;13(4):325–342.PubMed Dinan MA, Weinfurt KP, Friedman JY, Allsbrook JS, Gottlieb J, Schulman KA, et al. Comparison of conflict of interest policies and reported practices in academic medical centers in the United States. Accountability in Research. 2006;13(4):325–342.PubMed
15.
Zurück zum Zitat Center for Health & Pharmaceutical Law & Policy. Conflicts of Interest in Clinical Trial Recruitment and Enrollment: A Call for Increased Oversight. Newark, New Jersey: Seton Hall University School of Law; 2009. Center for Health & Pharmaceutical Law & Policy. Conflicts of Interest in Clinical Trial Recruitment and Enrollment: A Call for Increased Oversight. Newark, New Jersey: Seton Hall University School of Law; 2009.
16.
Zurück zum Zitat Hall MA, Weinfurt KP, Lawlor JS, Friedman JY, Schulman KA, Sugarman J. Community hospital oversight of clinical investigators’ financial relationships. IRB. 2009;31(1):7–13.PubMed Hall MA, Weinfurt KP, Lawlor JS, Friedman JY, Schulman KA, Sugarman J. Community hospital oversight of clinical investigators’ financial relationships. IRB. 2009;31(1):7–13.PubMed
17.
Zurück zum Zitat Lemmens T, Miller PB. The human subjects trade: ethical and legal issues surrounding recruitment incentives. Journal of Law, Medicine & Ethics. 2003;31(3):398–418.CrossRef Lemmens T, Miller PB. The human subjects trade: ethical and legal issues surrounding recruitment incentives. Journal of Law, Medicine & Ethics. 2003;31(3):398–418.CrossRef
Metadaten
Titel
Oversight of Financial Conflicts of Interest in Commercially Sponsored Research in Academic and Nonacademic Settings
verfasst von
Kevin P. Weinfurt, PhD
Mark A. Hall, JD
N. Chantelle Hardy
Joëlle Y. Friedman, MPA
Kevin A. Schulman, MD
Jeremy Sugarman, MD, MPH, MA
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 5/2010
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1264-6

Weitere Artikel der Ausgabe 5/2010

Journal of General Internal Medicine 5/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.